Synergistic inhibition of progesterone receptor‐A/B signalling by simvastatin and mifepristone in human uterine leiomyomas
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.1672 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Sadia Afrin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Mifepristone, Leiomyoma, Simvastatin, Receptors, Progesterone. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
- Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Mostafa A Borahay
Förderung
- NICHD NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Afrin, S., Kirschen, G. W., Miyashita-Ishiwata, M., El Sabeh, M., & Borahay, M. A. (2024). Synergistic inhibition of progesterone receptor‐A/B signalling by simvastatin and mifepristone in human uterine leiomyomas. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1672
Vancouver
Afrin S, Kirschen GW, Miyashita-Ishiwata M, El Sabeh M, Borahay MA. Synergistic inhibition of progesterone receptor‐A/B signalling by simvastatin and mifepristone in human uterine leiomyomas. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1672
BibTeX
@article{Afrin2024,
author = {Afrin, Sadia and Kirschen, Gregory W and Miyashita-Ishiwata, Mariko and El Sabeh, Malak and Borahay, Mostafa A},
title = {Synergistic inhibition of progesterone receptor‐A/B signalling by simvastatin and mifepristone in human uterine leiomyomas},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.1672}
}
EUVIMED